Chemical Structure : ALG1001
货号: PC-35165Not For Human Use, Lab Use Only.
ALG1001 (Risuteganib, ALG-1001) is a first-in-class, RGD class oligopeptide that inhibits integrin receptors (αvβ3, αvβ5, and α5β1) associated with angiogenesis.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
ALG1001 (Risuteganib, ALG-1001) is a first-in-class, RGD class oligopeptide that inhibits integrin receptors (αvβ3, αvβ5, and α5β1) associated with angiogenesis; ALG1001 inhibits an integrin-mediated pathway of the vitreoretinal interface, connecting the posterior aspect of the vitreous with the internal limiting membrane of the retina. In blocking this pathway, ALG-1001 helps to achieve vitreous breakdown and separation from the retina.
Other Indication
Phase 2 Clinical
分子量 | 637.666 | |
分子式 | C22H39N9O11S | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright